gs4 10 neratinib fulvestrant trastuzumab for hormone receptor-positive, her2-mutant metastatic
Published 1 year ago • 62 plays • Length 21:00
Download video MP4
Download video MP3
Similar videos
-
2:49
neratinib, trastuzumab fulvestrant for her2-mutant, hr , metastatic breast cancer
-
4:52
neratinib fulvestrant trastuzumab for hr her2-mutant mbc and neratinib trastuzumab for tr...
-
7:30
neratinib plus fulvestrant for her2 mutant, non-amplified metastatic breast cancer
-
5:02
samuraciclib in combination with fulvestrant in patients with advanced hr /her2- breast cancer
-
1:01
what emerald phase iii trial could mean for breast cancer patients | virginia kaklamani, md
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
2:00
neratinib after trastuzumab-based adjuvant therapy in her 2 positive breast cancer (extenet)
-
0:53
eleanor: real-world study of extended adjuvant neratinib in her2 /hr early breast cancer
-
2:57
key data from the san antonio breast cancer symposium (sabcs) 2022
-
3:27
alpelisib plus fulvestrant for hormone receptor positive metastatic breast cancer
-
1:20
final results from the phase 2 summit basket trial: targeting her2 advanced btcs with neratinib
-
2:34
eleanor: real-world use of neratinib in her2 , early breast cancer
-
4:34
lasofoxifene vs fulvestrant for locally advanced/metastatic er /her2- breast cancer: elaine trial
-
0:59
ribociclib in adjuvant hr breast cancer
-
15:53
gs3 -05: "fulvestrant-palbociclib vs continuing aromatase inhibitor-palbociclib upon detection..."
-
15:13
gs3-10: "study of samuraciclib (ct7001), a first-in-class, oral, selective inhibitor of cdk7, in.."
-
38:22
adjuvant/neoadjuvant therapy for breast cancer: updates and molecular predictors of benefit
-
3:03
phase ii trial of patritumab deruxtecan in metastatic breast cancer
-
0:49
san antonio breast cancer symposium 2022 highlights
Clip.africa.com - Privacy-policy